Gregg LoCascio, Michael Glick, Tracie Bryant and their team at Kirkland & Ellis secured a defense verdict in California state ...

US aid freeze sows disruption in HIV, malaria product supply chains Medtronic ... on strength in heart devices February 11, 2025 Abbott Laboratories on Wednesday forecast 2025 profit that came ...

"Abbott Laboratories began its 125th year with approximately ... "For our shareholders, we are developing the kind of essential, life-enhancing products that will ensure the enduring growth ...

Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $136.99, which the company achieved on February ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit of $1.34 per share was in line with ...

Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures and sells healthcare products worldwide. It is set to report its Q1 2025 earnings on April 16. Wall Street analysts expect the company ...

Strategic Financial Concepts LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The ...

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products. Valued at $229.1 billion by market cap, ABT is a global leader in the ...